167 related articles for article (PubMed ID: 28875419)
1. Lactulose decreases neuronal activation and attenuates motor behavioral deficits in hyperammonemic rats.
Mendes NF; Mariotti FFN; de Andrade JS; de Barros Viana M; Céspedes IC; Nagaoka MR; Le Sueur-Maluf L
Metab Brain Dis; 2017 Dec; 32(6):2073-2083. PubMed ID: 28875419
[TBL] [Abstract][Full Text] [Related]
2. Behavioral alterations and Fos protein immunoreactivity in brain regions of bile duct-ligated cirrhotic rats.
Le Sueur-Maluf L; Viana MB; Nagaoka MR; Amorim AL; Cardoso AN; Rodrigues BC; Mendes NF; Bittencourt JC; Céspedes IC
An Acad Bras Cienc; 2015 Mar; 87(1):331-493. PubMed ID: 25714078
[TBL] [Abstract][Full Text] [Related]
3. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy.
Rodrigo R; Cauli O; Gomez-Pinedo U; Agusti A; Hernandez-Rabaza V; Garcia-Verdugo JM; Felipo V
Gastroenterology; 2010 Aug; 139(2):675-84. PubMed ID: 20303348
[TBL] [Abstract][Full Text] [Related]
4. Chrysin, a flavonoid attenuates histological changes of hyperammonemic rats: A dose dependent study.
Renuka M; Vijayakumar N; Ramakrishnan A
Biomed Pharmacother; 2016 Aug; 82():345-54. PubMed ID: 27470372
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.
Poo JL; Góngora J; Sánchez-Avila F; Aguilar-Castillo S; García-Ramos G; Fernández-Zertuche M; Rodríguez-Fragoso L; Uribe M
Ann Hepatol; 2006; 5(4):281-8. PubMed ID: 17151582
[TBL] [Abstract][Full Text] [Related]
6. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis.
Jover R; Rodrigo R; Felipo V; Insausti R; Sáez-Valero J; García-Ayllón MS; Suárez I; Candela A; Compañ A; Esteban A; Cauli O; Ausó E; Rodríguez E; Gutiérrez A; Girona E; Erceg S; Berbel P; Pérez-Mateo M
Hepatology; 2006 Jun; 43(6):1257-66. PubMed ID: 16729306
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
[TBL] [Abstract][Full Text] [Related]
8. AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile duct-ligated rats.
Bosoi CR; Parent-Robitaille C; Anderson K; Tremblay M; Rose CF
Hepatology; 2011 Jun; 53(6):1995-2002. PubMed ID: 21384402
[TBL] [Abstract][Full Text] [Related]
9. The effects of sodium deoxycholate, lactulose and glutamine on bacterial translocation in common bile duct ligated rats.
Erbil Y; Berber E; Ozarmagan S; Seven R; Eminoglu L; Calis A; Olgaç V; Gürler N
Hepatogastroenterology; 1999; 46(29):2791-5. PubMed ID: 10576346
[TBL] [Abstract][Full Text] [Related]
10. Effects of lactulose and silymarin on liver enzymes in cirrhotic rats.
Ghobadi Pour M; Mirazi N; Alaei H; Moradkhani S; Rajaei Z; Monsef Esfahani A
Can J Physiol Pharmacol; 2017 May; 95(5):522-529. PubMed ID: 28281782
[TBL] [Abstract][Full Text] [Related]
11. Lactulose attenuates METH-induced neurotoxicity by alleviating the impaired autophagy, stabilizing the perturbed antioxidant system and suppressing apoptosis in rat striatum.
Xie XL; He JT; Wang ZT; Xiao HQ; Zhou WT; Du SH; Xue Y; Wang Q
Toxicol Lett; 2018 Jun; 289():107-113. PubMed ID: 29550550
[TBL] [Abstract][Full Text] [Related]
12. Bile-duct ligation renders the brain susceptible to hypotension-induced neuronal degeneration: Implications of ammonia.
Clément MA; Bosoi CR; Oliveira MM; Tremblay M; Bémeur C; Rose CF
J Neurochem; 2021 May; 157(3):561-573. PubMed ID: 33382098
[TBL] [Abstract][Full Text] [Related]
13. Bile duct ligation plus hyperammonemia in rats reproduces the alterations in the modulation of soluble guanylate cyclase by nitric oxide in brain of cirrhotic patients.
Rodrigo R; Jover R; Candela A; Compañ A; Sáez-Valero J; Erceg S; Felipo V
Neuroscience; 2005; 130(2):435-43. PubMed ID: 15664700
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-γ activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis.
Aghaei I; Shabani M; Doustar N; Nazeri M; Dehpour A
Pharmacol Biochem Behav; 2014 May; 120():133-9. PubMed ID: 24631483
[TBL] [Abstract][Full Text] [Related]
15. The bile duct ligated rat: A relevant model to study muscle mass loss in cirrhosis.
Bosoi CR; Oliveira MM; Ochoa-Sanchez R; Tremblay M; Ten Have GA; Deutz NE; Rose CF; Bemeur C
Metab Brain Dis; 2017 Apr; 32(2):513-518. PubMed ID: 27981407
[TBL] [Abstract][Full Text] [Related]
16. Vitamin K1 attenuates bile duct ligation-induced liver fibrosis in rats.
Jiao K; Sun Q; Chen B; Li S; Lu J
Scand J Gastroenterol; 2014 Jun; 49(6):715-21. PubMed ID: 24742111
[TBL] [Abstract][Full Text] [Related]
17. Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats.
Abdel Kawy HS
Eur J Pharmacol; 2015 Apr; 752():8-17. PubMed ID: 25666386
[TBL] [Abstract][Full Text] [Related]
18. Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia.
Jamshidzadeh A; Heidari R; Abasvali M; Zarei M; Ommati MM; Abdoli N; Khodaei F; Yeganeh Y; Jafari F; Zarei A; Latifpour Z; Mardani E; Azarpira N; Asadi B; Najibi A
Biomed Pharmacother; 2017 Feb; 86():514-520. PubMed ID: 28024286
[TBL] [Abstract][Full Text] [Related]
19. Genetically engineered E. coli Nissle attenuates hyperammonemia and prevents memory impairment in bile-duct ligated rats.
Ochoa-Sanchez R; Oliveira MM; Tremblay M; Petrazzo G; Pant A; Bosoi CR; Perreault M; Querbes W; Kurtz CB; Rose CF
Liver Int; 2021 May; 41(5):1020-1032. PubMed ID: 33548108
[TBL] [Abstract][Full Text] [Related]
20. Interorgan metabolism of ornithine phenylacetate (OP)--a novel strategy for treatment of hyperammonemia.
Dadsetan S; Sørensen M; Bak LK; Vilstrup H; Ott P; Schousboe A; Jalan R; Keiding S; Waagepetersen HS
Biochem Pharmacol; 2013 Jan; 85(1):115-23. PubMed ID: 23103564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
